AAAAAA

   
Results: 1-9 |
Results: 9
Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling
Authors: Lovshin, J Estall, J Yusta, B Brown, TJ Drucker, DJ
Citation: J. Lovshin et al., Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling, J BIOL CHEM, 276(24), 2001, pp. 21489-21499
Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor
Authors: Boushey, RP Yusta, B Drucker, DJ
Citation: Rp. Boushey et al., Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor, CANCER RES, 61(2), 2001, pp. 687-693
The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway
Authors: Yusta, B Boushey, RP Drucker, DJ
Citation: B. Yusta et al., The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway, J BIOL CHEM, 275(45), 2000, pp. 35345-35352
Enteroendocrine localization of GLP-2 receptor expression in humans and rodents
Authors: Yusta, B Huang, L Munroe, D Wolff, G Fantaske, R Sharma, S Demchyshyn, L Asa, SL Drucker, DJ
Citation: B. Yusta et al., Enteroendocrine localization of GLP-2 receptor expression in humans and rodents, GASTROENTY, 119(3), 2000, pp. 744-755
Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine
Authors: Lovshin, J Yusta, B Iliopoulos, I Migirdicyan, A Dableh, L Brubaker, PL Drucker, DJ
Citation: J. Lovshin et al., Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine, ENDOCRINOL, 141(11), 2000, pp. 4194-4201
Structural determinants for activity of glucagon-like peptide-2
Authors: DaCambra, MP Yusta, B Sumner-Smith, M Crivici, A Drucker, DJ Brubaker, PL
Citation: Mp. Dacambra et al., Structural determinants for activity of glucagon-like peptide-2, BIOCHEM, 39(30), 2000, pp. 8888-8894
Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Authors: Drucker, DJ Yusta, B Boushey, RP DeForest, L Brubaker, PL
Citation: Dj. Drucker et al., Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis, AM J P-GAST, 39(1), 1999, pp. G79-G91
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
Authors: Boushey, RP Yusta, B Drucker, DJ
Citation: Rp. Boushey et al., Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis, AM J P-ENDO, 277(5), 1999, pp. E937-E947
Biologic properties and therapeutic potential of glucagon-like peptide-2
Authors: Drucker, DJ Boushey, RP Wang, F Hill, ME Brubaker, PL Yusta, B
Citation: Dj. Drucker et al., Biologic properties and therapeutic potential of glucagon-like peptide-2, J PARENT EN, 23(5), 1999, pp. S98-S100
Risultati: 1-9 |